active substance: thiotriazolin; 1 ml of solution contains morpholine salt of thiazothic acid (thiotriazolin) in terms of 100% substance – 10 mg; 1 ml of solution contains 20 drops; excipients: sodium chloride, methylcellulose, water for injections.
Eye drops.
Slightly opalescent, colorless or with a slightly yellowish tint liquid.
Ophthalmological agents. ATC code S01X A.
The pharmacological effect of thiotriazolin is due to the activation of the antioxidant system of enzymes and the inhibition of lipid peroxidation processes in ischemic areas of eye tissues, reduction of the severity of neurotrophic disorders, increase in the intensity and rate of reparative processes, reduction of inflammatory reactions of tissues, improvement of blood flow in the microcirculatory bed of the eye. The preparation promotes early recovery of corneal sensitivity, formation of a more delicate haze, significant reduction of various complications, reduces manifestations of visual asthenopia, improves functional indicators of the accommodative muscle and central parts of the retina, which improves the functional ability of the eyes.
Not studied.
Eye injuries and burns, inflammatory and dystrophic diseases of the cornea, viral conjunctivitis. For the prevention of eye inflammation, reduction of visual asthenopia in individuals working with personal computers.
Increased sensitivity to the preparation.
Unknown.
None.
No contraindications.
Does not affect.
The preparation is prescribed from the first days of the disease in the form of instillation of 2 drops 3-4 times a day into the conjunctival sac of the affected eye.
Instillations of Thiotriazolin are carried out for 14-15 days. If necessary, the treatment course can be extended to 30 days.
For individuals working with personal computers, the preparation is prescribed in the form of instillations of 2 drops immediately before the start of work, and then every 2 hours. The duration of application is determined individually by the doctor.
Since the preparation is stored at a temperature of 2-8 °C after opening the vial, it must be warmed to room temperature before use.
There is no experience with the use of the preparation in children, so it is not recommended to prescribe the preparation to this age group of patients.
When following the recommended doses, overdose is impossible.
Usually, the preparation is well tolerated, possible reactions at the site of administration. With increased individual sensitivity, allergic reactions are possible, including itching, hyperemia.
There have been reports of non-serious adverse events.
2 years.
After opening the vial, store at a temperature between 2 °C and 8 °C for 5 days.
Store in the original packaging at a temperature not exceeding 25 °C.
Store in a place inaccessible to children.
1 vial with a dropper cap in a pack.
By prescription.
Joint-Stock Company "Kyivmedpreparat).
Ukraine, 01032, Kyiv, Saksaganskogo Street, 139.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.